A critical appraisal of existing concepts for the grouping of nanomaterials.

The grouping of substances serves to streamline testing for regulatory purposes. General grouping approaches for chemicals have been implemented in, e.g., the EU chemicals regulation. While specific regulatory frameworks for the grouping of nanomaterials are unavailable, this topic is addressed in different publications, and preliminary guidance is provided in the context of substance-related legislation or the occupational setting. The European Centre for Ecotoxicology and Toxicology of Chemicals Task Force on the Grouping of Nanomaterials reviewed available concepts for the grouping of nanomaterials for human health risk assessment. In their broad conceptual design, the evaluated approaches are consistent or complement each other. All go beyond the determination of mere structure-activity relationships and are founded on different aspects of the nanomaterial life cycle. These include the NM's material properties and biophysical interactions, specific types of use and exposure, uptake and kinetics, and possible early and apical biological effects. None of the evaluated grouping concepts fully take into account all of these aspects. Subsequent work of the Task Force will aim at combining the available concepts into a comprehensive 'multiple perspective' framework for the grouping of nanomaterials that will address all of the mentioned aspects of their life cycles.

[1]  A. Nel,et al.  Self-organizing map analysis of toxicity-related cell signaling pathways for metal and metal oxide nanoparticles. , 2011, Environmental science & technology.

[2]  Robert Landsiedel,et al.  Inhalation studies for the safety assessment of nanomaterials: status quo and the way forward. , 2012, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[3]  David Y Lai,et al.  Toward toxicity testing of nanomaterials in the 21st century: a paradigm for moving forward. , 2012, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[4]  Craig A. Poland,et al.  Nanotoxicity: challenging the myth of nano-specific toxicity. , 2013, Current opinion in biotechnology.

[5]  A. Nel,et al.  Classification NanoSAR development for cytotoxicity of metal oxide nanoparticles. , 2011, Small.

[6]  Christian Micheletti,et al.  Weight of Evidence approach for the relative hazard ranking of nanomaterials , 2011, Nanotoxicology.

[7]  R Damoiseaux,et al.  No time to lose--high throughput screening to assess nanomaterial safety. , 2011, Nanoscale.

[8]  Myrtill Simkó,et al.  Metrics, Dose, and Dose Concept: The Need for a Proper Dose Concept in the Risk Assessment of Nanoparticles , 2014, International journal of environmental research and public health.

[9]  Albrecht Poth,et al.  Worldwide Trend in Nanomaterial Safety Evaluation , 2012 .

[10]  Rong Liu,et al.  Implementation of a multidisciplinary approach to solve complex nano EHS problems by the UC Center for the Environmental Implications of Nanotechnology. , 2013, Small.

[11]  Iseult Lynch,et al.  The evolution of the protein corona around nanoparticles: a test study. , 2011, ACS nano.

[12]  Aravind Subramanian,et al.  Perturbational profiling of nanomaterial biologic activity , 2008, Proceedings of the National Academy of Sciences.

[13]  Marco P Monopoli,et al.  Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.

[14]  Hugh J. Byrne,et al.  Concern-driven integrated approaches to nanomaterial testing and assessment – report of the NanoSafety Cluster Working Group 10 , 2013, Nanotoxicology.

[15]  Robert Landsiedel,et al.  Toxico-/biokinetics of nanomaterials , 2012, Archives of Toxicology.

[16]  Karin Wiench,et al.  Geeignete Methoden zur Prüfung der Sicherheit von Nanomaterialien , 2008 .

[17]  N. Carmichael,et al.  European Centre for Ecotoxicology and Toxicology of Chemicals , 2014 .

[18]  Alexandra Kroll,et al.  Testing Metal‐Oxide Nanomaterials for Human Safety , 2010, Advanced materials.

[19]  Mark Bradley,et al.  Predictive value of in vitro assays depends on the mechanism of toxicity of metal oxide nanoparticles , 2013, Particle and Fibre Toxicology.

[20]  Stella M. Marinakos,et al.  Characterization of physicochemical properties of nanomaterials and their immediate environments in high-throughput screening of nanomaterial biological activity. , 2013, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[21]  Jürgen Schnekenburger,et al.  Pulmonary toxicity of nanomaterials: a critical comparison of published in vitro assays and in vivo inhalation or instillation studies. , 2014, Nanomedicine.

[22]  Saji George,et al.  A predictive toxicological paradigm for the safety assessment of nanomaterials. , 2009, ACS nano.

[23]  Nicholas Ball,et al.  Use of category approaches, read-across and (Q)SAR: general considerations. , 2013, Regulatory toxicology and pharmacology : RTP.

[24]  Bengt Fadeel,et al.  Nanosafety in Europe 2015-2020: Towards Safe and Sustainable Nanomaterials and Nanotechnology Innovations , 2013 .

[25]  Paul A Schulte,et al.  Workshop report: strategies for setting occupational exposure limits for engineered nanomaterials. , 2014, Regulatory toxicology and pharmacology : RTP.

[26]  Lutz Mädler,et al.  Nanomaterials in the environment: from materials to high-throughput screening to organisms. , 2011, ACS nano.

[27]  David Vernez,et al.  Development of a control banding tool for nanomaterials , 2012 .

[28]  Lutz Mädler,et al.  Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation. , 2012, ACS nano.

[29]  Karen Blackburn,et al.  A framework for using structural, reactivity, metabolic and physicochemical similarity to evaluate the suitability of analogs for SAR-based toxicological assessments. , 2010, Regulatory toxicology and pharmacology : RTP.

[30]  P. A. Schulte,et al.  Development of risk-based nanomaterial groups for occupational exposure control , 2012, Journal of Nanoparticle Research.

[31]  Robert Rallo,et al.  Use of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterials. , 2011, ACS nano.

[32]  Lang Tran,et al.  ITS-NANO - Prioritising nanosafety research to develop a stakeholder driven intelligent testing strategy , 2014, Particle and Fibre Toxicology.

[33]  Iseult Lynch,et al.  Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.

[34]  Xiang Wang,et al.  Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening. , 2013, Accounts of chemical research.

[35]  B. Rehn,et al.  Ein neues In-vitro-Prüfkonzept (Vektorenmodell) zum biologischen Screening und Monitoring der Lungentoxizität von Stäuben : Darstellung des Konzeptes und Überprüfung mit Stöuben bekannter Wirkung , 1999 .

[36]  Robert Landsiedel,et al.  Concern-Driven Safety Assessment of Nanomaterials: An Integrated Approach Using Material Properties, Hazard, Biokinetic, and Exposure Data and Considerations on Grouping and Read-Across , 2014 .

[37]  W. Russell,et al.  Ethical and Scientific Considerations Regarding Animal Testing and Research , 2011, PloS one.

[38]  Wouter Fransman,et al.  Stoffenmanager Nano version 1.0: a web-based tool for risk prioritization of airborne manufactured nano objects. , 2012, The Annals of occupational hygiene.

[39]  Christie M Sayes,et al.  A framework for grouping nanoparticles based on their measurable characteristics , 2013, International journal of nanomedicine.

[40]  Karen Blackburn,et al.  A framework to facilitate consistent characterization of read across uncertainty. , 2014, Regulatory toxicology and pharmacology : RTP.

[41]  S. Schulte,et al.  Safety evaluation of sunscreen formulations containing titanium dioxide and zinc oxide nanoparticles in UVB sunburned skin: an in vitro and in vivo study. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.